Nantahala Capital Management - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2019$2,272,000
-40.0%
238,945
-44.1%
0.07%
-38.8%
Q4 2018$3,785,000
-44.1%
427,710
-28.9%
0.12%
-36.3%
Q3 2018$6,769,000
-35.9%
601,710
-27.1%
0.18%
-57.5%
Q2 2018$10,560,000825,0000.43%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 11,826,299$130,562,0004.09%
MPM BioImpact LLC 1,200,000$13,248,0003.68%
Finepoint Capital LP 960,200$10,601,0003.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,011$273,000,0002.85%
Avoro Capital Advisors LLC 9,220,000$101,789,0002.01%
Long Focus Capital Management, LLC 1,625,000$17,940,0001.88%
683 Capital Management, LLC 2,000,000$22,080,0001.56%
Parametrica Management Ltd 115,870$1,268,0001.38%
Boxer Capital, LLC 1,935,133$21,364,0001.35%
Soleus Capital Management, L.P. 719,600$7,944,0001.24%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders